ZA202108150B - An inhalable fixed dose powder composition comprising glycopyrronium, formoterol and fluticasone propionate - Google Patents
An inhalable fixed dose powder composition comprising glycopyrronium, formoterol and fluticasone propionateInfo
- Publication number
- ZA202108150B ZA202108150B ZA2021/08150A ZA202108150A ZA202108150B ZA 202108150 B ZA202108150 B ZA 202108150B ZA 2021/08150 A ZA2021/08150 A ZA 2021/08150A ZA 202108150 A ZA202108150 A ZA 202108150A ZA 202108150 B ZA202108150 B ZA 202108150B
- Authority
- ZA
- South Africa
- Prior art keywords
- glycopyrronium
- formoterol
- powder composition
- fixed dose
- fluticasone propionate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
- A61M15/0023—Mouthpieces therefor retractable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
- A61M11/003—Particle size control by passing the aerosol trough sieves or filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
- A61M15/0035—Piercing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
- A61M15/0041—Details of the piercing or cutting means with movable piercing or cutting means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2209/00—Ancillary equipment
- A61M2209/06—Packaging for specific medical equipment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201921020572 | 2019-05-24 | ||
IN201921023615 | 2019-06-14 | ||
IN201921029676 | 2019-07-23 | ||
PCT/IB2020/054774 WO2020240350A1 (en) | 2019-05-24 | 2020-05-20 | An inhalable fixed dose powder composition comprising glycopyrronium, formoterol and fluticasone propionate |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA202108150B true ZA202108150B (en) | 2023-03-29 |
Family
ID=73552696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2021/08150A ZA202108150B (en) | 2019-05-24 | 2021-10-22 | An inhalable fixed dose powder composition comprising glycopyrronium, formoterol and fluticasone propionate |
Country Status (4)
Country | Link |
---|---|
CO (1) | CO2021017397A2 (en) |
MX (1) | MX2021014343A (en) |
WO (1) | WO2020240350A1 (en) |
ZA (1) | ZA202108150B (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9700135D0 (en) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
ITMO20020297A1 (en) * | 2002-10-16 | 2004-04-17 | Roberto Oliva | INHALER FOR SINGLE-DOSE PREPARATIONS IN CAPSULES. |
EP2749283A3 (en) * | 2011-02-17 | 2014-08-20 | Cipla Limited | Combination of glycopyrronium and olodaterol |
EA036153B1 (en) * | 2012-07-05 | 2020-10-06 | Арвен Айлак Санайи Ве Тиджарет А.С. | Pharmaceutical composition for inhalation, packed dosage form, capsule, method of treating obstructive airway diseases and pharmaceutical kit |
WO2014007781A2 (en) * | 2012-07-05 | 2014-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Inhalation compositions |
PL2821061T3 (en) * | 2013-07-01 | 2018-05-30 | Arven Ilac Sanayi Ve Ticaret A.S. | Novel inhalation formulations |
-
2020
- 2020-05-20 WO PCT/IB2020/054774 patent/WO2020240350A1/en active Application Filing
- 2020-05-20 MX MX2021014343A patent/MX2021014343A/en unknown
-
2021
- 2021-10-22 ZA ZA2021/08150A patent/ZA202108150B/en unknown
- 2021-12-17 CO CONC2021/0017397A patent/CO2021017397A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2021014343A (en) | 2022-01-06 |
WO2020240350A1 (en) | 2020-12-03 |
CO2021017397A2 (en) | 2022-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202110037B (en) | Nicotine pouch composition and pouch comprising such | |
IL284835A (en) | Pharmaceutical combination comprising tno155 and ribociclib | |
EP3297710A4 (en) | Propellant based metered dose inhaler and food applicators and applicators | |
HK1245125A1 (en) | Dry powder inhaler comprising fluticasone propionate and salmeterol xinafoat | |
IL287905A (en) | Pharmaceutical composition containing brexanolone, ganaxolone, or zuranolone, and use thereof | |
MX2015015132A (en) | Inhalable pharmaceutical compositions and the inhaler devices containing them. | |
EP3849404A4 (en) | Small highly uniform nanomedicine compositions for therapeutic, imaging and theranostic applications | |
EP4023227A4 (en) | Pharmaceutical composition and application thereof | |
IL272503A (en) | Pharmaceutical composition comprising abiraterone acetate and darulotamide | |
IL285378A (en) | Heterocyclic compound, pharmaceutical composition comprising same, preparation method therefor, and use thereof | |
SG11202103746QA (en) | Withania somnifera composition, method of preparation and use thereof | |
IL284099A (en) | Adeno-associated viruses and their uses for inner ear therapy | |
IL286642A (en) | Compositions, devices and methods for factor vii therapy | |
MX2018006799A (en) | Pharmaceutical composition. | |
EP3927328A4 (en) | Inhalable therapeutic agent | |
EP3347022A4 (en) | Pharmaceutical composition including dutasteride and capsule formulation comprising the same | |
ZA202108150B (en) | An inhalable fixed dose powder composition comprising glycopyrronium, formoterol and fluticasone propionate | |
EP3861988A4 (en) | Powder inhaler, method for assessing same, and use of same | |
SI3768241T1 (en) | Topical composition comprising calcipotriol and betamethasone dipropionate | |
SG11202012005VA (en) | Fluticasone furoate nasal preparation composition | |
IL284132A (en) | Pharmaceutical compound, the method of its making and use as medicinal agent | |
IL285977A (en) | Adeno-associated viruses and their uses for inner ear therapy | |
ZA202104261B (en) | Combination pharmaceutical compositions and methods thereof | |
EP3981422C0 (en) | Pharmaceutical composition containing lysozyme and use thereof | |
EP3983050A4 (en) | Medicament containment devices and associated compositions |